Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib:...

Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma

Luke, J. J., Hodi, F. S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2012-0391
Date:
June, 2013
File:
PDF, 1.27 MB
english, 2013
Conversion to is in progress
Conversion to is failed